eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Craniofacial Surgery

Craniofacial Distraction Osteogenesis

Author: Mario J Imola, MD, DDS, FRCSC, FACS, Consulting Staff, Department of Otolaryngology-Head & Neck Surgery, Center for Craniofacial and Skull Base Surgery
Contributor Information and Disclosures

Updated: Jun 30, 2009

Introduction

History of the Procedure

Distraction osteogenesis (DO), a well-established technique used for several decades by orthopedic surgeons to repair long bone defects, has, over the past 15 years, gained acceptance for correction of various craniofacial deformities. Bone distraction is not a new concept. Distraction was introduced first by Codvilla nearly a hundred years ago and was subsequently popularized during the 1940s by Ilizarov, who developed a single-stage procedure to lengthen long bones without the use of grafting material.1 The feasibility of applying Ilizarov's principles to different craniofacial deformities was not considered until several decades after his pioneering work in the peripheral skeleton.

In the purest sense, the first reports of craniofacial DO were in the early 1960s, when rapid expansion of the palate was carried out in growing patients. This practice, however, involved distraction of a naturally occurring physis. Finally, in 1973, Snyder first described the Ilizarov technique to lengthen a surgical osteotomy of the canine mandible. Interest in craniofacial distraction at first grew slowly, with sporadic experimental reports appearing over the ensuing 2 decades. However, in the early 1990s, experimental investigation intensified following reports from New York University on lengthening of dog mandibles and from Constantino and Friedman et al, who used DO to successfully close canine segmental lower jaw defects.2

Thereafter, several studies (within various animal models) demonstrated the application of osteodistraction at a number of different sites, including the mandible, lower maxilla, mid face, and cranial vault. In 1992, the first clinical results of craniofacial DO were reported by McCarthy et al in a small series of patients with congenital mandible deformities.3 Since then, several larger series with longer follow-up periods have appeared. More recently, the technique has been successfully used for midfacial and upper craniofacial skeletal defects.

Intraoperative photographs of distractor placemen...

Intraoperative photographs of distractor placement.

Intraoperative photographs of distractor placemen...

Intraoperative photographs of distractor placement.



Typical airway changes after mandibular distracti...

Typical airway changes after mandibular distraction.

Typical airway changes after mandibular distracti...

Typical airway changes after mandibular distraction.


Problem

The underlying principle of DO, as described by Ilizarov, is "the mechanical induction of new bone between bony surfaces that are gradually distracted." The process of DO begins with careful preoperative assessment and planning, which are critical to success. At the initial surgery, osteotomies are performed and the distraction device is inserted. A waiting period (latency phase) is allowed to elapse during which bone healing is initiated at the bony gap. In this early period, periosteal integrity is restored and callus formation begins. The bone segments at either end of the gap are then progressively distracted over a period of several days (distraction phase) during which osteogenesis is induced, thus producing a so-called regenerate of immature bone laid down between the cut bone ends. Over time, the bone remodels into a more mature state (consolidation phase), and the surrounding soft tissues adapt to their new positions and lengths.

Pathophysiology

The histology and physiologic principles underlying DO have been well documented in long bones and, more recently, in the craniofacial skeleton. During the distraction phase, bone formation occurs in response to tension-stress forces exerted on the regenerate, and healing proceeds primarily by a regenerative membranous ossification process. The middle of the regenerate consists of a fibrous central zone where osteoid is deposited with collagen fibers oriented parallel to the direction of distraction.

Ossification occurs as a primary mineralization front advances from either end of the fibrous central zone, resulting in a bridge of immature bone across the distraction gap. Bone remodeling begins during the consolidation phase and continues over 1-2 years, eventually transforming the regenerate into a mature osseous structure similar in size and shape to the adjacent bone. Although the volume of new bone is comparable to that of adjacent bones, animal studies show that mineral content and radiodensity is approximately 30% less, as is the tensile strength of the regenerated segment.

In addition to bony changes, effects on the adjacent soft tissue occur in response to osseous distraction. Muscle and soft tissue mass increase via a process referred to as distraction histogenesis. Clinically, this offers a distinct advantage because several craniofacial anomalies have soft tissue hypoplasia in addition to deficient bony structures. Neurovascular elements contained within distracted bony segments are also stimulated to regenerate. Experimental studies in dogs demonstrate regeneration of the mandibular canal containing both neural and vascular elements. However, the functional level of the regenerated neurovascular structures is less than normal.

A number of factors are known to influence the physiologic process of DO, and these can be separated into 2 basic groups: bone factors and distraction factors.

Bone factors

Osteocyte viability is essential to provide an adequate source of osteoblastic activity at the distraction site; hence, exercise careful surgical technique to minimize thermal or mechanical bone injury. Similarly, an adequate blood supply to the distraction site is critical to osteogenesis. Arterial insufficiency may lead to ischemic fibrogenesis within the regenerate, yielding a loose irregular collagen network instead of the desirable dense regular collagen pattern. Venous outflow obstruction has been associated with cystic degeneration of the regenerate.

The clinician, therefore, must ensure that soft tissues surrounding the site of proposed distraction are well vascularized. Early studies in long bones concluded that both an intact periosteum and endosteum were critical to successful osteogenesis; therefore, many advocated that a corticotomy be performed only through a minimal periosteal opening. More recently, however, investigators have demonstrated that the periosteum alone can provide sufficient osteogenic capacity for a healthy regenerate, and this is especially true in the well-vascularized membranous bone of the craniofacial skeleton.

Therefore, while some clinicians advocate a corticotomy, most reports of craniofacial DO describe the use of a complete osteotomy (taking care to preserve as much of the surrounding periosteum as possible). Prior radiation therapy to the distraction site does not adversely influence the results of distraction (in the canine model), and when using DO to repair segmental defects, the status of the surrounding soft tissues probably is the key factor influencing outcome.

Distraction factors

The latency, rate, and rhythm of distraction are all known to influence the quality of the regenerate. Of these factors, the effect of latency is the most controversial. Most craniofacial surgeons have empirically applied the conclusions from long bone studies and recommend waiting 4-7 days following osteotomy before initiating the distraction process. In younger children, the high rate of bone metabolism would favor a shorter waiting period.4,5 Some clinicians, however, use a zero latency period and begin distracting upon appliance insertion, claiming no adverse effects on outcome, while substantially shortening the treatment period.

Waiting too long prior to distraction (ie, >10-14 d) substantially increases the risk of premature bone union. In contrast to latency, the rate and frequency (ie, rhythm) of distraction are considered important variables. If widening of the osteotomy site occurs too rapidly (ie, > 2 mm/d), then a fibrous nonunion results, whereas if the rate is too slow (ie, <0.5 mm/d), then premature bony union prevents lengthening to the desired length. These findings in long bones have been empirically applied to the craniofacial skeleton, and most studies have described a rate of 1.0 mm/d.

According to Ilizarov's work in long bones, the ideal rhythm is a continuous form of distraction; however, this is impractical on a clinical basis.1 Therefore, most reports have used distraction frequencies of 1-2 times daily. The length of the consolidation phase has been recommended to range from 6-12 weeks in long bones, depending on the length of the distraction segment. In the craniofacial skeleton, most authors advocate a range of 4-8 weeks. The general rule holds that the consolidation period should be at least twice the duration of the distraction phase.

Finally, appliance rigidity during distraction and consolidation is a critical element to ensure that bending or shearing forces do not result in microfractures of the immature columns of new bone within the regenerate, which lead to focal hemorrhage and cartilage interposition.

Indications

Craniofacial DO is well accepted for several underlying disorders. Distraction osteogenesis (DO) has also been described for several less common etiologies, albeit on a more sporadic basis. Current usage falls into 3 broad groups as follows:

Lower face (mandible)

  • Most common application to date
  • Unilateral distraction of the ramus, angle, or posterior body for hemifacial microsomia
  • Bilateral advancement of the body for severe micrognathia, particularly in infants and children with airway obstruction as observed in the Pierre Robin syndrome
  • Vertical distraction of alveolar segments to correct an uneven occlusal plane or to facilitate implantation into edentulous zones
  • Horizontal distraction across the midline to correct crossbite deformities or to improve arch form

Mid face (maxilla, orbits)6

  • Advance the lower maxilla at the LeFort I level
  • Complete midfacial advancement at the LeFort III level
  • Closure of alveolar bony gaps associated with cleft lip and palate deformities

Upper face (fronto-orbital, cranial vault)

  • Advancement of the fronto-orbital bandeau, alone or in combination with the mid face as a monobloc or facial bipartition
  • New use of distraction as a means of cranial vault remodeling by gradual separation across resected stenotic sutures

Established indications for craniofacial DO include the following:

Congenital indications

  • Nonsyndromic craniosynostosis - Coronal (bilateral or unilateral) or sagittal
  • Syndromic craniosynostosis - Apert, Crouzon, and Pfeiffer syndromes
  • Cleft lip and palate
  • Hemifacial microsomia
  • Pierre Robin syndrome7

Acquired indications

  • Posttraumatic deformity (midfacial retrusion or mandibular collapse)
  • Atrophy of edentulous segments
  • Oncologic mandible defects

Relevant Anatomy

See Pathophysiology.

Contraindications

Several factors can limit or preclude the use of distraction osteogenesis (DO) to correct craniofacial deformities. Few absolute contraindications to the use of this technique exist; however, caution is advised in patients who, for one reason or another, will not comply with the distraction regime.

From a surgical standpoint, an adequate bone stock is necessary to accept the distraction appliances and to provide suitable opposing surfaces capable of generating a healing callus. Therefore, in patients who have undergone several craniofacial procedures in the past, the facial skeleton may exist in several small discontinuous fragments unsuitable for distraction. In these cases, bone grafting the gaps first may be possible, followed by distraction on a delayed basis.

Age should also influence the surgeon's decision. Although distraction has enabled procedures to be performed in patients of a much younger age than with conventional craniofacial surgery, exercise caution in the very young because working with the small fragile bones in these patients becomes increasingly difficult. Also, remember that many relatively straightforward cases exist, in which equivalent results can be obtained with conventional techniques. In such scenarios, prudence calls for use of the time-tested procedures. Such caution is especially true in orthognathic repositioning for most dentofacial deformities.

More on Craniofacial Distraction Osteogenesis

Overview: Craniofacial Distraction Osteogenesis
Workup: Craniofacial Distraction Osteogenesis
Treatment: Craniofacial Distraction Osteogenesis
Follow-up: Craniofacial Distraction Osteogenesis
Multimedia: Craniofacial Distraction Osteogenesis
References
Further Reading

References

  1. Ilizarov GA. The principles of the Ilizarov method. Bull Hosp Jt Dis Orthop Inst. Spring 1988;48(1):1-11. [Medline].

  2. Costantino PD, Friedman CD, Shindo ML, et al. Experimental mandibular regrowth by distraction osteogenesis. Long-term results. Arch Otolaryngol Head Neck Surg. May 1993;119(5):511-6. [Medline].

  3. McCarthy JG, Schreiber J, Karp N, et al. Lengthening the human mandible by gradual distraction. Plast Reconstr Surg. Jan 1992;89(1):1-8; discussion 9-10. [Medline].

  4. Tibesar RJ, Sidman JD. Mandibular distraction osteogenesis in the pediatric patient. Curr Opin Otolaryngol Head Neck Surg. Dec 2008;16(6):548-54. [Medline].

  5. Higuera S, Cole P, Stephenson JB, Hollier L. Distraction rate and latency: factors in the outcome of paediatric maxillary distraction. J Plast Reconstr Aesthet Surg. Nov 5 2008;[Medline].

  6. Reddy LV, Elhadi HM. Maxillary advancement by distraction osteogenesis. Atlas Oral Maxillofac Surg Clin North Am. Sep 2008;16(2):237-47. [Medline].

  7. Dauria D, Marsh JL. Mandibular distraction osteogenesis for Pierre Robin sequence: what percentage of neonates need it?. J Craniofac Surg. Sep 2008;19(5):1237-43. [Medline].

  8. Al-Daghreer S, Flores-Mir C, El-Bialy T. Long-term stability after craniofacial distraction osteogenesis. J Oral Maxillofac Surg. Sep 2008;66(9):1812-9. [Medline].

  9. [Guideline] Persing J, James H, Swanson J, Kattwinkel J. Prevention and management of positional skull deformities in infants. American Academy of Pediatrics Committee on Practice and Ambulatory Medicine, Section on Plastic Surgery and Section on Neurological Surgery. Pediatrics. Jul 2003;112(1 Pt 1):199-202. [Medline].

  10. Cohen SR, Rutrick RE, Burstein FD. Distraction osteogenesis of the human craniofacial skeleton: initial experience with new distraction system. J Craniofac Surg. Sep 1995;6(5):368-74. [Medline].

  11. Imola MJ. Craniofacial distraction osteogenesis. Current Opin Otolaryngol Head Neck Surg. 2001;9:238-248.

  12. Imola MJ, Hamlar DD, Thatcher G, et al. The versatility of distraction osteogenesis in craniofacial surgery. Arch Facial Plast Surg. Jan-Mar 2002;4(1):8-19. [Medline].

  13. Molina F, Ortiz Monasterio F. Mandibular elongation and remodeling by distraction: a farewell to majorosteotomies. Plast Reconstr Surg. Sep 1995;96(4):825-40; discussion 841-2. [Medline].

  14. Toth BA, Kim JW, Chin M, Cedars M. Distraction osteogenesis and its application to the midface and bony orbit in craniosynostosis syndromes. J Craniofac Surg. Mar 1998;9(2):100-13; discussion 119-22. [Medline].

Keywords

craniofacial distraction osteogenesis, distraction osteogenesis, craniofacial DO, DO, bone distraction, craniofacial deformities

Contributor Information and Disclosures

Author

Mario J Imola, MD, DDS, FRCSC, FACS, Consulting Staff, Department of Otolaryngology-Head & Neck Surgery, Center for Craniofacial and Skull Base Surgery
Mario J Imola, MD, DDS, FRCSC, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate/Craniofacial Association, American Head and Neck Society, American Laryngological Rhinological and Otological Society, American Medical Association, AO Foundation, Canadian Academy of Facial Plastic and Reconstructive Surgery, Canadian Society of Otolaryngology-Head & Neck Surgery, College of Physicians and Surgeons of Ontario, Colorado Medical Society, and North American Skull Base Society
Disclosure: Nothing to disclose.

Medical Editor

Jaime R Garza, MD, DDS, FACS, Consulting Staff, Private Practice
Jaime R Garza, MD, DDS, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Medical Association, American Society for Aesthetic Plastic Surgery, American Society of Maxillofacial Surgeons, Texas Medical Association, and Texas Society of Plastic Surgeons
Disclosure: Allergan Honoraria Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

David W Stepnick, MD, Associate Professor, Departments of Plastic Surgery and Otolaryngology-Head and Neck Surgery, Case Western Reserve University School of Medicine, University Hospitals of Cleveland Case Medical Center
David W Stepnick, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society for Head and Neck Surgery, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.